Elevance Health, Inc.
ELV
$336.36
-$3.04-0.90%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.53% | 16.24% | 14.70% | 3.10% | 4.50% |
| Total Other Revenue | 6.55% | 3.85% | 15.55% | 24.21% | 9.69% |
| Total Revenue | 12.33% | 14.04% | 14.83% | 6.55% | 5.36% |
| Cost of Revenue | 15.75% | 20.06% | 15.60% | 6.91% | 7.66% |
| Gross Profit | 3.07% | -0.03% | 12.87% | 5.56% | -0.38% |
| SG&A Expenses | 9.86% | 4.09% | 18.05% | 23.96% | -4.17% |
| Depreciation & Amortization | 32.79% | -9.26% | 33.62% | -17.05% | -42.45% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.47% | 16.06% | 16.20% | 10.47% | 4.47% |
| Operating Income | -26.11% | -12.99% | -1.97% | -58.94% | 24.31% |
| Income Before Tax | 2.40% | -23.24% | -4.83% | -39.46% | -16.99% |
| Income Tax Expenses | -40.00% | -20.00% | -11.16% | 13.53% | 3.11% |
| Earnings from Continuing Operations | 17.76% | -24.21% | -2.89% | -50.30% | -22.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -75.00% | 0.00% | 66.67% | -80.00% | 172.73% |
| Net Income | 17.03% | -24.22% | -2.80% | -51.17% | -21.18% |
| EBIT | -26.11% | -12.99% | -1.97% | -58.94% | 24.31% |
| EBITDA | -20.80% | -10.35% | -0.59% | -51.03% | 15.73% |
| EPS Basic | 21.54% | -21.86% | -0.10% | -50.18% | -20.02% |
| Normalized Basic EPS | -30.01% | -13.95% | -2.08% | -69.41% | 29.64% |
| EPS Diluted | 22.02% | -21.62% | 0.21% | -50.17% | -20.00% |
| Normalized Diluted EPS | -29.77% | -13.73% | -1.80% | -69.41% | 29.63% |
| Average Basic Shares Outstanding | -3.71% | -3.01% | -2.71% | -1.99% | -1.44% |
| Average Diluted Shares Outstanding | -4.03% | -3.26% | -2.99% | -1.99% | -1.44% |
| Dividend Per Share | 4.91% | 4.91% | 4.91% | 10.14% | 10.14% |
| Payout Ratio | -0.14% | 0.34% | 0.05% | 1.21% | 0.38% |